Tactile Systems Technology, Inc.

NASDAQ:TCMD

Medical - Devices

Healthcare
$26.42 +1.43%

+$0.37 today

Market cap
$591.84M
Beta
0.83
P/E (TTM)
29.1
EPS (TTM)
$0.90
52W Low $9.42High $37.77

Volume 0.22M

Average 0.30M

TCMD Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Tactile Systems Technology, Inc.NASDAQ: TCMD

Research & Development · Q1 FY2026 · quarter ended Mar 2026

Research & development growth accelerates

Q1 FY2026 research & development of $2.78M rose 59.4% year over year, ahead of the +12.9% change in trailing-twelve-month research & development. Sequentially, it rose 9.7% from the prior quarter. Over 3 fiscal years it compounded at +6.2% a year.

Context

  • Research & development amounted to 2.6% of revenue in FY2025, down 0.4 pp from a year earlier.
  • Research & development increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +59.4% holds above the trailing-twelve-month pace of +12.9%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$2.78M+9.7% QoQ
Last fiscal yearDec 2025
$8.48M-4.0% YoY
LTMMar 2026
$9.52M+12.9% YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+59.4%——
1 year-4.0%——
3-year CAGR+6.2%——
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
8.48M USD
Year-over-year change
-4.0%
4-year CAGR
+10.6%

Research & Development vs competitors

How TCMD compares with its peers on the latest reported figures

  • TCMD's LTM Mar 2026 research & development of $9.52M is the highest of the 2 companies compared; the peer median is $1.29M.
  • Its year-over-year change of +12.9% is the lowest of 2, against a peer median of +48.0%.
  • Research & development amounts to 2.8% of revenue for TCMD, versus a peer median of 1.8%.
TCMD Competitors Peer median
Research & Development for TCMD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TCMDTactile Systems Technology, Inc.LTM Mar 2026$9.52M +12.9%+6.2%2.8%
ELMDElectromed, Inc.LTM Mar 2026$1.29M +48.0%-9.8%1.8%
Peer median (excluding TCMD) $1.29M+48.0%-9.8%1.8%

Competitors are the stored peer set for TCMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue208.06M246.79M274.42M292.98M329.52M
Cost of Revenue59.84M70.81M79.29M76.3M81.82M
Gross Profit148.21M175.98M195.13M216.69M247.7M
Gross Margin71.2%71.3%71.1%74.0%75.2%
Research & Development5.66M7.09M7.82M8.83M8.48M
Selling, General & Admin143.58M167.21M169.19M183.14M209.94M
Operating Expenses149.98M188.73M177.09M194.51M218.42M
Depreciation & Amortization3.68M14.43M6.5M6.8M6.64M
EBITDA1.39M1.75M26.42M32.37M39.02M
EBITDA Margin0.7%0.7%9.6%11.0%11.8%
Operating Income(1.76M)(12.76M)18.04M22.18M29.28M
Operating Margin-0.8%-5.2%6.6%7.6%8.9%
Interest Income060K1.87M3.38M3.1M
Interest Expense02.79M4.15M2.09M1.04M
Other Income / Expenses(531K)(2.72M)(2.27M)1.31M2.06M
Income Before Tax(2.29M)(15.47M)15.77M23.49M31.34M
Pre-Tax Margin-1.1%-6.3%5.7%8.0%9.5%
Income Tax Expense9.52M2.39M(12.75M)6.53M12.25M
Net Income(11.81M)(17.87M)28.52M16.96M19.09M
Net Margin-5.7%-7.2%10.4%5.8%5.8%
EPS (Basic)(0.60)(0.89)1.240.710.83
EPS (Diluted)(0.60)(0.89)1.230.700.82
Weighted Avg Shares19.72M20.07M22.93M23.88M22.87M
Weighted Avg Shares (Diluted)19.72M20.07M23.18M24.14M23.3M

Tactile Systems Technology, Inc.

NASDAQ:TCMD

Intrinsic Alpha fair value

Locked

Current Price

$26.42

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.